Suppr超能文献

健康志愿者和膝骨关节炎患者中阿片类药物引起的步态可变性降低。

Opioid-Induced Reductions in Gait Variability in Healthy Volunteers and Individuals with Knee Osteoarthritis.

机构信息

The Parker Institute, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark.

Department of Physical and Occupational Therapy, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark.

出版信息

Pain Med. 2019 Nov 1;20(11):2106-2114. doi: 10.1093/pm/pny286.

Abstract

OBJECTIVE

To investigate differences in gait variability induced by two different single-dose opioid formulations and an inert placebo in healthy volunteers and knee osteoarthritis patients.

DESIGN

Experimental, randomized, double-blinded, crossover study of inert placebo (calcium tablets), 50 mg of tapentadol, and 100 mg of tramadol.

SETTING

Laboratory setting.

SUBJECTS

Healthy volunteers and knee osteoarthritis patients.

METHODS

At three visits, separated by seven days, one tablet was administered per visit according to the randomization code. At each visit, a baseline measurement was done before tablet administration, after which hourly measurements were performed for six hours, yielding a total of seven measurements per visit. Gait variability was measured by three-dimensional gait analysis, recorded during six minutes of continuous treadmill walking at self-selected speed. One hundred seventy gait cycles were identified from detection of clear events of the knee joint angle trajectories. Gait variability was assessed as average standard deviations over a gait cycle of the sacrum displacements and accelerations; sagittal plane ankle, knee, and hip joint angles; step widths; and stride times.

RESULTS

Twenty-four opioid-naïve and neurologically intact participants (12 healthy volunteers and 12 knee osteoarthritis patients) were included and completed the experiment. Tapentadol reduced the variability of sacrum displacements and accelerations compared with placebo and tramadol. There were no differences between experimental conditions regarding the variability in lower-extremity joint angle variability, step widths, or stride times.

CONCLUSIONS

In opioid-naïve and neurologically intact individuals, tapentadol seems to reduce movement variability during treadmill walking, compared with placebo and tramadol. This can be interpreted as a loss of adaptability that might increase the risk of falling if the system is perturbed.

摘要

目的

研究两种不同单剂量阿片类药物制剂和惰性安慰剂在健康志愿者和膝骨关节炎患者中引起的步态变化差异。

设计

健康志愿者和膝骨关节炎患者的随机、双盲、交叉实验,使用惰性安慰剂(钙片)、50 毫克曲马多和 100 毫克酒石酸布托啡诺。

设置

实验室设置。

对象

健康志愿者和膝骨关节炎患者。

方法

在三次就诊中,每次就诊间隔七天,根据随机代码服用一片。每次就诊时,在服药前进行基线测量,服药后每小时测量一次,每次就诊共测量七次。通过三维步态分析测量步态变化,在自行选择的速度下连续在跑步机上行走六分钟时进行记录。从膝关节角度轨迹的明显事件检测中确定了 170 个步态周期。通过评估骶骨位移和加速度的步态周期平均标准偏差;矢状面踝关节、膝关节和髋关节角度;步幅和步幅时间来评估步态变化。

结果

纳入并完成实验的有 24 名阿片类药物-naive 和神经功能完整的参与者(12 名健康志愿者和 12 名膝骨关节炎患者)。与安慰剂和曲马多相比,酒石酸布托啡诺降低了骶骨位移和加速度的变异性。在下肢关节角度变异性、步幅和步幅时间的变异性方面,各实验条件之间没有差异。

结论

在阿片类药物-naive 和神经功能完整的个体中,与安慰剂和曲马多相比,酒石酸布托啡诺似乎降低了跑步机行走时的运动变异性。这可以解释为适应性丧失,如果系统受到干扰,可能会增加跌倒的风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验